Molecule Holdings Statistics
Molecule Holdings (MLCL) Stock Statistics & Valuation Metrics
Total Valuation
Molecule Holdings has a market cap or net worth of CAD 488.91K. The enterprise value is CAD 5.60T.
- Market Cap
- CAD 488.91K
- Enterprise Value
- CAD 5.60T
Share Statistics
Molecule Holdings has 97,781,906 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 97,781,906
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Molecule Holdings’s return on equity (ROE) is 1.23 and return on invested capital (ROIC) is -250.72%.
- Return on Equity (ROE)
- 1.23
- Return on Assets (ROA)
- -1.16
- Return on Invested Capital (ROIC)
- -250.72%
- Return on Capital Employed (ROCE)
- 1.08
- Revenue Per Employee
- ―
- Profits Per Employee
- ―
- Employee Count
- 0
- Asset Turnover
- 0.50
- Inventory Turnover
- 5.01
Valuation Ratios
The current PE Ratio of Molecule Holdings is -0.11. Molecule Holdings’s PEG ratio is -0.01.
- PE Ratio
- -0.11
- PS Ratio
- 0.25
- PB Ratio
- -0.13
- Price to FCF
- -0.42
- Price to Operating Cash Flow
- -0.43
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Molecule Holdings had revenue of 1.97M and earned -4.54M in profits. Earnings per share was -0.05.
- Revenue
- 1.97M
- Gross Profit
- -1.07M
- Operating Income
- -3.91M
- Pretax Income
- -4.54M
- Net Income
- -4.54M
- EBITDA
- -3.26M
- Earnings Per Share (EPS)
- -0.05
Cash Flow
In the last 12 months, operating cash flow was -98.67K and capital expenditures -7, giving a free cash flow of -98.67K billion.
- Operating Cash Flow
- -98.67K
- Free Cash Flow
- -98.67K
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Molecule Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -237.77%
- Earnings Yield
- -935.80%
Stock Price Statistics
- Beta
- 0.00
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- 10.06K
Financial Position
Molecule Holdings as a current ratio of 0.17, with Debt / Equity ratio of -140.63%
- Current Ratio
- 0.17
- Quick Ratio
- 0.09
- Debt to Market Cap
- 1.17
- Net Debt to EBITDA
- -1.32
- Interest Coverage Ratio
- -6.17
Taxes
In the past 12 months, Molecule Holdings has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Molecule Holdings EV to EBITDA ratio is -1.72, with an EV/FCF ratio of -4.82.
- EV to Sales
- 2.85
- EV to EBITDA
- -1.72
- EV to Free Cash Flow
- -4.82
- EV to Operating Cash Flow
- -4.96
Balance Sheet
Molecule Holdings has CAD 141.93K in cash and marketable securities with CAD 5.83M in debt, giving a net cash position of -CAD 5.69M billion.
- Cash & Marketable Securities
- CAD 141.93K
- Total Debt
- CAD 5.83M
- Net Cash
- -CAD 5.69M
- Net Cash Per Share
- -CAD 0.06
- Tangible Book Value Per Share
- -CAD 0.06
Margins
Gross margin is -54.56%, with operating margin of -198.86%, and net profit margin of -230.84%.
- Gross Margin
- -54.56%
- Operating Margin
- -198.86%
- Pretax Margin
- -230.84%
- Net Profit Margin
- -230.84%
- EBITDA Margin
- -165.47%
- EBIT Margin
- -198.59%
Analyst Forecast
The average price target for Molecule Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
